
Matthew Mossanen
Physician · Mass General Brigham
Credentials: · · · ·
History
- Present
Mass General Brigham · Brigham and Women's Hospital · Dana-Farber Cancer Institute
- 2017–2018
- 2012–2017
Urology

2006–2010
Research
The burden of bladder cancer care: direct and indirect costs
Review · Current Opinion in Urology · 2014 · First of 2 authors · 173 citations
A neoantigen vaccine generates antitumour immunity in renal cell carcinoma
Nature · 2025 · 164 citations
Individual, interpersonal, and organisational factors of healthcare conflict: A scoping review
Journal of Interprofessional Care · 2017 · 91 citations

46 papers

37 papers

30 papers · 2 as a fellow

28 papers
- GS
19 papers

19 papers

16 papers

15 papers
Clinical trials
- 2023–2026
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
Principal investigator · Recruiting
Dana-Farber Cancer Institute
- 2022–2026
- 2026–2029
Site PI · Not yet recruiting · Phase 1
UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.
- 2023–2026
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Site PI · Recruiting · Phase 1, Phase 2
SURGE Therapeutics


